Growth Metrics

Wave Life Sciences (WVE) Cash from Operations Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 60.84%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 85.14%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -15.72%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 74.39%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 3.23%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 158.60%
10 Wave Life Sciences 1.32 Bn 772.50 Mn - 5.53%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.53%
Dec 31, 2025 22.62%
Sep 30, 2025 3.90%
Jun 30, 2025 -67.51%
Mar 31, 2025 -88.56%
Dec 31, 2024 -31.32%
Sep 30, 2024 -34.89%
Jun 30, 2024 26.27%
Mar 31, 2024 -139.09%
Dec 31, 2023 0.60%
Sep 30, 2023 -34.36%
Jun 30, 2023 -29.27%
Mar 31, 2023 314.49%
Dec 31, 2022 -375.47%
Sep 30, 2022 9.01%
Jun 30, 2022 -206.58%
Mar 31, 2022 10.15%
Dec 31, 2021 77.61%
Sep 30, 2021 -39.72%
Jun 30, 2021 75.35%
Mar 31, 2021 -69.05%
Dec 31, 2020 48.70%
Sep 30, 2020 53.82%
Jun 30, 2020 -15.84%
Mar 31, 2020 47.90%
Dec 31, 2019 -86.59%
Sep 30, 2019 -50.57%
Jun 30, 2019 -146.12%
Mar 31, 2019 -55.37%
Dec 31, 2018 -44.24%
Sep 30, 2018 -23.92%
Jun 30, 2018 455.41%
Mar 31, 2018 -86.16%
Dec 31, 2017 -70.48%
Sep 30, 2017 -97.86%
Jun 30, 2017 -5,250.77%
Mar 31, 2017 -144.09%
Dec 31, 2016 -100.16%
Sep 30, 2016 -315.45%
Jun 30, 2016 128.02%
Mar 31, 2016 -340.77%
Dec 31, 2015 -441.23%